Digestive Surgery

Original Paper

Prognostic Factors after Curative Resection for Single-Lesion Hepatocellular Carcinoma in Patients with Normal Liver Function: A Historical Cohort Study

Shimoda M.a · Tago K.b · Kato M.b · Aoki T.b · Kubota K.b

Author affiliations

aDepartment of Gastroenterological Surgery, Tokyo Medical University, Ibaraki Medical Center, Ibaraki, and bSecond Department of Surgery, Dokkyo Medical University, Mibu, Japan

Keywords: Anatomical resectionLimited resectionHepatocellular carcinoma

Related Articles for ""
Dig Surg 2017;34:281-288
https://doi.org/10.1159/000451066

Log in to MyKarger to check if you already have access to this content.




Forgot your password
Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates

Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: June 18, 2016
Accepted: September 20, 2016
Published online: January 19, 2017
Issue release date: July 2017

Number of Print Pages: 8
Number of Figures: 3
Number of Tables: 5

ISSN: 0253-4886 (Print)
eISSN: 1421-9883 (Online)

For additional information: https://www.karger.com/DSU

Abstract

Background: Hepatic resection for hepatocellular carcinoma (HCC) is now established as the treatment most likely to yield the best outcome. We aimed to clarify the risk factors for HCC recurrence after curative resection of single HCC in patients with normal liver function (NLF). Methods: The clinical records of 105 patients with NFL and a single HCC less than 5 cm in diameter who had undergone curative liver resection between April 2000 and January 2013 were investigated. We analyzed risk factors for recurrence of HCC. Results: Forty of the 105 patients suffered recurrence of HCC, and median recurrence-free survival (RFS) was 22.0 (5.1-148.5) months after surgery, and the liver was the most frequent site of recurrence. Univariate analysis showed that limited resection (LR; p = 0.002), the indocyanine green retention rate at 15 min (p = 0.023), C-reactive protein value (p = 0.001), bilirubin value (p = 0.042), neutrophil to lymphocyte ratio (p = 0.042), operation time (p = 0.018), and amount of bleeding (p = 0.011) were associated with RFS. Multivariate analysis showed that LR (p = 0.007) was a significant risk factor associated with RFS. Conclusion: LR is a risk factor for HCC recurrence in patients with single-lesion HCC and NLF.

© 2017 S. Karger AG, Basel



Related Articles:

References

  1. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236.
  2. Kitisin K, Packiam V, Steel J, et al: Presentation and outcomes of hepatocellular carcinoma patients at a western centre. HPB (Oxford) 2011;13:712-722.
  3. Ishizuka M, Kubota K, Kita J, et al: Impact of an inflammation-based prognostic system on patients undergoing surgery for hepatocellular carcinoma: a retrospective study of 398 Japanese patients. Am J Surg 2012;203:101-106.
  4. Aino H, Sumie S, Niizeki T, et al: Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis. Mol Clin Oncol 2014;2:393-398.
  5. Sohn W, Paik YH, Kim JM, et al: HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma. Ann Surg Oncol 2014;21:2429-2435.
  6. Kim SU, Jung KS, Lee S, et al: Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma. Liver Int 2014;34:1008-1017.
  7. Du ZG, Wei YG, Chen KF, Li B: Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution's experience with 398 consecutive patients. Hepatobiliary Pancreat Dis Int 2014;13:153-161.
  8. Arnaoutakis DJ, Mavros MN, Shen F, et al: Recurrence patterns and prognostic factors in patients with hepatocellular carcinoma in noncirrhotic liver: a multi-institutional analysis. Ann Surg Oncol 2014;21:147-154.
  9. Yuki K, Hirohashi S, Sakamoto M, et al: Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer 1990;66:2174-2179.
  10. Eguchi S, Kanematsu T, Arii S, et al: Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 2008;143:469-475.
  11. Kishi Y, Hasegawa K, Kaneko J, et al: Resection of segment VIII for hepatocellular carcinoma. Br J Surg 2012;99:1105-1112.
  12. Utsunomiya T, Shimada M, Kudo M, et al: Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact. Ann Surg 2014;259:336-345.
  13. Strasberg SM, Phillips C: Use and dissemination of the brisbane 2000 nomenclature of liver anatomy and resections. Ann Surg 2013;257:377-382.
  14. Makuuchi M, Kosuge T, Takayama T, et al: Surgery for small liver cancers. Semin Surg Oncol 1993;9:298-304.
  15. Makuuchi M, Hasegawa H, Yamazaki S: Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 1985;161:346-350.
  16. Couinaud C: [Liver lobes and segments: notes on the anatomical architecture and surgery of the liver]. Presse Med 1954;62:709-712.
  17. Chen YL, Ko CJ, Chien SY, et al: Tumor size as a prognostic factor in resected small hepatocellular carcinoma: a controversy revisited. J Gastroenterol Hepatol 2011;26:851-857.
  18. Miyaaki H, Nakashima O, Kurogi M, et al: Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma. J Gastroenterol 2007;42:962-968.
  19. Brown DB, Fundakowski CE, Lisker-Melman M, et al: Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol 2004;15:1209-1218.
  20. Jonas S, Bechstein WO, Steinmuller T, et al: Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;33:1080-1086.
  21. Castaing D, Garden OJ, Bismuth H: Segmental liver resection using ultrasound-guided selective portal venous occlusion. Ann Surg 1989;210:20-23.
  22. Kosuge T, Makuuchi M, Takayama T, et al: Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology 1993;40:328-332.
  23. Regimbeau JM, Kianmanesh R, Farges O, et al: Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 2002;131:311-317.
  24. Yamamoto Y, Ikoma H, Morimura R, et al: Clinical analysis of anatomical resection for the treatment of hepatocellular carcinoma based on the stratification of liver function. World J Surg 2014;38:1154-1163.
  25. Hasegawa K, Kokudo N, Imamura H, et al: Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 2005;242:252-259.
  26. Kaibori M, Matsui Y, Hijikawa T, et al: Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C. Surgery 2006;139:385-394.
  27. Wakai T, Shirai Y, Sakata J, et al: Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma. Ann Surg Oncol 2007;14:1356-1365.
  28. Tanaka K, Shimada H, Matsumoto C, et al: Anatomic versus limited nonanatomic resection for solitary hepatocellular carcinoma. Surgery 2008;143:607-615.
  29. Yamazaki O, Matsuyama M, Horii K, et al: Comparison of the outcomes between anatomical resection and limited resection for single hepatocellular carcinomas no larger than 5 cm in diameter: a single-center study. J Hepatobiliary Pancreat Sci 2010;17:349-358.
  30. Ochiai T, Ikoma H, Yamamoto Y, et al: Anatomical hepatectomy for hepatocellular carcinoma in patients with preserved liver function. Anticancer Res 2013;33:1689-1695.
  31. Takamoto T, Hashimoto T, Ogata S, et al: Planning of anatomical liver segmentectomy and subsegmentectomy with 3-dimensional simulation software. Am J Surg 2013;206:530-538.
  32. Hariyama M, Shimoda M: Automatic estimation of resected liver region using a tumor domination ratio; in Deligiannidis L, Arabnia H (eds): Emerging Trends in Image Processing, Computer Vision and Pattern Recognition, ed 1. New York, Elsevier, 2015, pp 369-378.
  33. Hariyama M, Okada M, Shimoda M, et al: Estimation of resected liver regions using a tumor domination ratio. Las Vegas, International Conference on Image Processing, Computer Vision, and Pattern Recognition, IPCV'14, 2014, pp 52-56.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: June 18, 2016
Accepted: September 20, 2016
Published online: January 19, 2017
Issue release date: July 2017

Number of Print Pages: 8
Number of Figures: 3
Number of Tables: 5

ISSN: 0253-4886 (Print)
eISSN: 1421-9883 (Online)

For additional information: https://www.karger.com/DSU

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

2017, Vol.34, No. 4

July 2017

Article

Recommend This
TOP